About
I am the first University appointed Chair of Ophthalmology. I have built a Vision Science research department and led and developed the University Hospital BOB体育登录网址_欧宝体育官网平台-APP|下载 medical retinal service.
Research
Research groups
Research interests
- Ocular clinical trials
- Age related macular degeneration
- Central serous chorioretinopathy
- Inherited retinal diseases
- Gene therapy
Current research
I am currently leading a UK multi-centre clinical trial evaluating photodynamic laser treatment for central serous chorioretinopathy funded by the NIHR and an international research project funded by the Wellcome Trust evaluating machine learning as a tool to better understand age related macular degeneration (AMD). In addition I am participating in a number of clinical trials at different stages evaluating novel treatments for AMD and inherited retinal diseases. Current laboratory work includes developing cell models of AMD and assessing the value of gene therapy in AMD. I collaborate widely and often with my BOB体育登录网址_欧宝体育官网平台-APP|下载 Vision Science colleagues Drs Ratnajaka and Lakowski.
Research projects
Active projects
Completed projects
Publications
Teaching
I teach medical students when they rotate through ophthalmology and junior ophthalmologists via weekly medical retinal teaching and our postgraduate class.
I supervise PhD (clinical and scientific) students and medical students undertaking intercalated research degrees.
External roles and responsibilities
Biography
Andrew Lotery is an ophthalmologist with major research interests in age-related macular degeneration, central serous chorio-retinopathy and inherited retinal diseases. He has been awarded the Nettleship Award for best research published by a UK ophthalmologist in the past 3 years by the Royal College of Ophthalmologists and was listed by the Times as one of the United Kingdom’s top 100 doctors. He has been recognised for his research by the University Hospital BOB体育登录网址_欧宝体育官网平台-APP|下载 Innovation and Researcher of the Year awards and a Macular Society award. He was awarded the Hendkind lecture by the Macula Society for outstanding retinal research in 2024. He was editor in chief of the scientific journal, Eye for 10 years and is past Chair of the Scientific Committee and now Honorary Secretary of the Royal College of Ophthalmologists. He has served two times as an NIHR Senior Investigator. His research has been funded by the Wellcome Trust, NIHR and eye research charities. He has served as Chair of several national eye research advisory boards for Sight Research UK and Retina UK and sat on research committees for the Medical Research Council and Wellcome Trust. He is currently the Chair of the Macular Society Research Committee and Specialist lead for the NIHR Research Delivery Network. He established the University of BOB体育登录网址_欧宝体育官网平台-APP|下载 Gift of Sight Appeal to raise funds to support vision research.
Prizes
- NIHR Senior Investigator (2016)
- Jesse Mole Medal, Retina UK (2019)
- Clinical impact through research award, University Hospital BOB体育登录网址_欧宝体育官网平台-APP|下载 (2017)
- Gold ACCEA clinical excellence award (2017)
- Renewal of NIHR Senior Investigator Award (2017)
- Platinum ACCEA clinical excellence award (2021) (2021)
- NIHR Senior Investigator (2016)
- Jesse Mole Medal, Retina UK (2019)
- Clinical impact through research award, University Hospital BOB体育登录网址_欧宝体育官网平台-APP|下载 (2017)
- Gold ACCEA clinical excellence award (2017)
- Renewal of NIHR Senior Investigator Award (2017)
- Platinum ACCEA clinical excellence award (2021) (2021)
- awarded for presenting Paul Henkind Memorial lecture (2024)